Topical composite hydrogel incorporating human amniotic membrane and spidroin for the treatment of chronic wounds in diabetes mellitus

Background and purpose: Traditional diabetic chronic skin wound dressings often lack the bioactivity required to promote regeneration in these complex wounds. The use of human amniotic membrane (hAM) has been identified as a promising natural option for diabetic skin wound regeneration, but hAM is...

Full description

Saved in:
Bibliographic Details
Main Authors: Suyarta Efrida Pakpahan, Anggraini Barlian, Arie Wibowo, Indra Wibowo
Format: Article
Language:English
Published: International Association of Physical Chemists (IAPC) 2025-08-01
Series:ADMET and DMPK
Subjects:
Online Access:https://pub.iapchem.org/ojs/index.php/admet/article/view/2822
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849223272598601728
author Suyarta Efrida Pakpahan
Anggraini Barlian
Arie Wibowo
Indra Wibowo
author_facet Suyarta Efrida Pakpahan
Anggraini Barlian
Arie Wibowo
Indra Wibowo
author_sort Suyarta Efrida Pakpahan
collection DOAJ
description Background and purpose: Traditional diabetic chronic skin wound dressings often lack the bioactivity required to promote regeneration in these complex wounds. The use of human amniotic membrane (hAM) has been identified as a promising natural option for diabetic skin wound regeneration, but hAM is susceptible to rejection and release of growth factors, so cells must be decellularized and supplemented with biomaterials such as spidroin, a hydrogel delivery system. This study aims to analyse and evaluate a composite hydrogel combining hAM and spidroin proteins to enhance the healing of diabetic chronic wounds. Experimental approach: Hydrogels were synthesized and characterized using scanning electron microscope (SEM), attenuated total reflectance Fourier transform infrared spectroscopy, physical tests, gel fraction and swelling ratio. Wound healing studies were performed using alloxan-induced diabetic mice. Full-thickness wounds were created and treated with the hydrogel formulations. Macroscopic progress of wound healing was monitored, and histological analysis was performed to assess reepithelialization, inflammatory response, and collagen deposition. Key results: The functional groups of hAMD components were identified at the characteristic absorption peaks of 1650 cm⁻¹, while spidroin showed a peak at 1530 cm⁻¹. In particular, the 10 % composite (hAMD + spidroin) showed significantly faster wound closure compared to the control group and other treatment groups. Histological findings confirmed that the 10 % composite was able to facilitate cell proliferation, reduce inflammation, enhance epithelial regeneration, angiogenesis, fibroblast formation and regular collagen matrix and decrease transforming growth factor beta in the remodelling phase. Conclusion: Composite (hAMD + spidroin) 10 % showed promising wound healing efficacy in diabetic conditions, indicating its potential as a bioactive wound dressing for chronic diabetes.
format Article
id doaj-art-8f3399fe430d442d8bc70101b8216842
institution Kabale University
issn 1848-7718
language English
publishDate 2025-08-01
publisher International Association of Physical Chemists (IAPC)
record_format Article
series ADMET and DMPK
spelling doaj-art-8f3399fe430d442d8bc70101b82168422025-08-25T19:45:59ZengInternational Association of Physical Chemists (IAPC)ADMET and DMPK1848-77182025-08-0110.5599/admet.2822Topical composite hydrogel incorporating human amniotic membrane and spidroin for the treatment of chronic wounds in diabetes mellitusSuyarta Efrida Pakpahan0https://orcid.org/0000-0002-5596-4224Anggraini Barlian1https://orcid.org/0000-0002-0826-3134Arie Wibowo2https://orcid.org/0000-0002-0581-2433Indra Wibowo3https://orcid.org/0000-0001-7197-2075Doctoral Program of Biology, School of Life Sciences and Technology, Institut Teknologi Bandung, Ganesha, 10, Bandung, 40132, Jawa Barat, IndonesiaAnimal Physiology, Development and Biomedical Sciences Research Group, School of Life Sciences and Technology, Institut Teknologi Bandung, Ganesha, 10, Bandung, 40132, Jawa Barat, Indonesia and Scientific Imaging Center, Institut Teknologi Bandung, Ganesha, 10, Bandung, 40132, Jawa Barat, IndonesiaMaterials Science and Engineering Research Group, Faculty of Mechanical and Aerospace Engineering, Institut Teknologi Bandung, Jl. Ganesha, 10, Bandung, 40132, Jawa Barat, IndonesiaAnimal Physiology, Development and Biomedical Sciences Research Group, School of Life Sciences and Technology, Institut Teknologi Bandung, Ganesha, 10, Bandung, 40132, Jawa Barat, Indonesia Background and purpose: Traditional diabetic chronic skin wound dressings often lack the bioactivity required to promote regeneration in these complex wounds. The use of human amniotic membrane (hAM) has been identified as a promising natural option for diabetic skin wound regeneration, but hAM is susceptible to rejection and release of growth factors, so cells must be decellularized and supplemented with biomaterials such as spidroin, a hydrogel delivery system. This study aims to analyse and evaluate a composite hydrogel combining hAM and spidroin proteins to enhance the healing of diabetic chronic wounds. Experimental approach: Hydrogels were synthesized and characterized using scanning electron microscope (SEM), attenuated total reflectance Fourier transform infrared spectroscopy, physical tests, gel fraction and swelling ratio. Wound healing studies were performed using alloxan-induced diabetic mice. Full-thickness wounds were created and treated with the hydrogel formulations. Macroscopic progress of wound healing was monitored, and histological analysis was performed to assess reepithelialization, inflammatory response, and collagen deposition. Key results: The functional groups of hAMD components were identified at the characteristic absorption peaks of 1650 cm⁻¹, while spidroin showed a peak at 1530 cm⁻¹. In particular, the 10 % composite (hAMD + spidroin) showed significantly faster wound closure compared to the control group and other treatment groups. Histological findings confirmed that the 10 % composite was able to facilitate cell proliferation, reduce inflammation, enhance epithelial regeneration, angiogenesis, fibroblast formation and regular collagen matrix and decrease transforming growth factor beta in the remodelling phase. Conclusion: Composite (hAMD + spidroin) 10 % showed promising wound healing efficacy in diabetic conditions, indicating its potential as a bioactive wound dressing for chronic diabetes. https://pub.iapchem.org/ojs/index.php/admet/article/view/2822Argiope appensachronic diabetic woundin vivotransforming growth factor beta
spellingShingle Suyarta Efrida Pakpahan
Anggraini Barlian
Arie Wibowo
Indra Wibowo
Topical composite hydrogel incorporating human amniotic membrane and spidroin for the treatment of chronic wounds in diabetes mellitus
ADMET and DMPK
Argiope appensa
chronic diabetic wound
in vivo
transforming growth factor beta
title Topical composite hydrogel incorporating human amniotic membrane and spidroin for the treatment of chronic wounds in diabetes mellitus
title_full Topical composite hydrogel incorporating human amniotic membrane and spidroin for the treatment of chronic wounds in diabetes mellitus
title_fullStr Topical composite hydrogel incorporating human amniotic membrane and spidroin for the treatment of chronic wounds in diabetes mellitus
title_full_unstemmed Topical composite hydrogel incorporating human amniotic membrane and spidroin for the treatment of chronic wounds in diabetes mellitus
title_short Topical composite hydrogel incorporating human amniotic membrane and spidroin for the treatment of chronic wounds in diabetes mellitus
title_sort topical composite hydrogel incorporating human amniotic membrane and spidroin for the treatment of chronic wounds in diabetes mellitus
topic Argiope appensa
chronic diabetic wound
in vivo
transforming growth factor beta
url https://pub.iapchem.org/ojs/index.php/admet/article/view/2822
work_keys_str_mv AT suyartaefridapakpahan topicalcompositehydrogelincorporatinghumanamnioticmembraneandspidroinforthetreatmentofchronicwoundsindiabetesmellitus
AT anggrainibarlian topicalcompositehydrogelincorporatinghumanamnioticmembraneandspidroinforthetreatmentofchronicwoundsindiabetesmellitus
AT ariewibowo topicalcompositehydrogelincorporatinghumanamnioticmembraneandspidroinforthetreatmentofchronicwoundsindiabetesmellitus
AT indrawibowo topicalcompositehydrogelincorporatinghumanamnioticmembraneandspidroinforthetreatmentofchronicwoundsindiabetesmellitus